Excellos Ensures Reliability And Patient Safety With XiltriX

In 2023, Excellos — a leading provider of custom cGMP services supporting the development and manufacturing of advanced cell therapies — expanded operations into a new state-of-the-art GMP facility in San Diego. As part of their innovative workflow, Excellos cryopreserves leukapheresis material from cancer patients prior to shipping it to centralized manufacturing sites, ensuring the integrity of this critical starting material for life-saving therapies.

Before this expansion, a missed alarm event at their former facility exposed gaps in their environmental monitoring infrastructure, highlighting a broader industry challenge faced by many biotechnology and pharmaceutical organizations. Rather than treating it as an isolated incident, Excellos took decisive action to prevent future risks by forming a strategic partnership with XiltriX, a trusted leader in real-time environmental monitoring with over four decades of experience in the life sciences sector.

See how this collaboration significantly improved system reliability and monitoring oversight, reinforcing Excellos' dedication to product quality, operational excellence, and — most importantly — patient safety.